Why the study?
It was unknown whether women with gestational diabetes mellitus in the third trimester of pregnancy exhibit adverse alterations in myocardial energetics, function, or tissue characteristics.
Do women with obesity and gestational diabetes mellitus exhibit adverse cardiac alterations in myocardial energetics, function, or tissue characteristics compared to healthy pregnant women?
Do women with obesity and gestational diabetes mellitus exhibit adverse cardiac alterations in myocardial energetics, function, or tissue characteristics compared to healthy pregnant women?
Women with obesity and gestational diabetes mellitus in late pregnancy exhibit impaired myocardial contractility, higher LV mass, and reduced myocardial energetics compared to healthy pregnant women, which may contribute to long-term cardiovascular risk.
Myocardial energetics changes in GDM merit longitudinal follow-up; leaves open whether they predict postpartum cardiovascular risk.
OBJECTIVE: We investigated if women with gestational diabetes mellitus (GDM) in the third trimester of pregnancy exhibit adverse cardiac alterations in myocardial energetics, function, or tissue characteristics. RESEARCH DESIGN AND METHODS: Thirty-eight healthy, pregnant women and 30 women with GDM were recruited. Participants underwent phosphorus MRS and cardiovascular magnetic resonance for assessment of myocardial energetics (phosphocreatine [PCr] to ATP ratio), tissue characteristics, biventricular volumes and ejection fractions, left ventricular (LV) mass, global longitudinal shortening (GLS), and mitral in-flow E-wave to A-wave ratio. RESULTS: Participants were matched for age, gestational age, and ethnicity. The following data are reported as mean ± SD. The women with GDM had higher BMI (27 ± 4 vs. 33 ± 5 kg/m2; P = 0.0001) and systolic (115 ± 11 vs. 121 ± 13 mmHg; P = 0.04) and diastolic (72 ± 7 vs. 76 ± 9 mmHg; P = 0.04) blood pressures. There was no difference in N-terminal pro-brain natriuretic peptide concentrations between the groups. The women with GDM had lower myocardial PCr to ATP ratio (2.2 ± 0.3 vs. 1.9 ± 0.4; P < 0.0001), accompanied by lower LV end-diastolic volumes (76 ± 12 vs. 67 ± 11 mL/m2; P = 0.002) and higher LV mass (90 ± 13 vs. 103 ± 18 g; P = 0.001). Although ventricular ejection fractions were similar, the GLS was reduced in women with GDM (-20% ± 3% vs. -18% ± 3%; P = 0.008). CONCLUSIONS: Despite no prior diagnosis of diabetes, women with obesity and GDM manifest impaired myocardial contractility and higher LV mass, associated with reductions in myocardial energetics in late pregnancy compared with lean women with healthy pregnancy. These findings may aid our understanding of the long-term cardiovascular risks associated with GDM.
No takes yet. Share an insight, caveat, or question.
Thirunavukarasu et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: